Barbara Oil Co. Gilead Sciences, Inc. Transaction History

Barbara Oil Co.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $605,400 - $790,000	-10,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $142,300 - $167,040	2,000 Added 25.0%	10,000 $716,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $576,880 - $683,760	8,000	8,000 $648,000

1,927

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Barbara Oil Co., based on Form 13F filings with the SEC.

Stay updated on Barbara Oil Co. with notifications on news.